PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies

Inclusion Criteria

• •Patient ≥70 years
• •Non-small-cell lung cancer for which the multidisciplinary consultation required systemic treatment regardless of Tumor-Node-Metastasis (TNM) stage
• •Patient naïve to systemic anticancer treatment for bronchial neoplasia
• •Patient covered by social security
• •Patient eligible for systemic treatment
• •Systemic treatment with marketing authorization in the indication, available in routine care early access or compassionate access.
• •Patient able to understand the protocol
• •Patient not opposed to the collection of data concerning him/her
• •Signature of study consent form.